the relationship between in vitro leukemic cell growth kinetics , intracellular biochemical pharmacology of 1-beta-d-arabinofuranosylcytosine ( ara-c ) , and clinical response to ara-c-containing timed sequential therapy was examined in leukemic marrow populations from 62 adults with acute myelogenous leukemia ( aml ) .
C1517806
leukemic cell
C0220615
adults